Jan 24, 2023 / 09:30PM GMT
Operator
Hello, and welcome to the Precigen Virtual R&D Day for PRGN 2012. At this time all participants are in listen-only mode (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Steve Harasym. Please go ahead.
Steven Harasym - Precigen, Inc. - VP & Head of IR
Thank you, Kevin, and thank you to all joining us for this update call today. Before we begin, I'd remind everyone that today's call will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ from those indicated by our forward-looking statements. Please read the safe harbor statements contained in this presentation as well as the risk factors contained in Precigen's most recent SEC filings for a more complete discussion on these risks and uncertainties.
Today, I am pleased to be joined by Dr. Helen Sabzevari, President and CEO of Precigen; and Dr. Clint
Precigen Inc R&D Day Transcript
Jan 25, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers